What type of study is this?

This is a Human Clinical Trial study (also classified as: RCT).

November 30, 2025DEN OpenOpen Access

Inhibitory Effect of Lidocaine on Duodenal Peristalsis During Endoscopic Retrograde Cholangiopancreatography: A Multicenter, Randomized Controlled Trial (With Video)

View Full Paper

Ask AI

Bookmark

Lidocaine inhibited duodenal peristalsis by 94.4%, contrasting with 52.6% in the control group, showing a significant improvement.
The trial involved 40 elderly patients, with 19 receiving lidocaine and 21 receiving a control jelly, emphasizing the study's multicenter approach.
Randomized controlled trial method utilized computer-generated randomization, ensuring robust allocation of patients to either treatment group.
Lidocaine demonstrates potential as a safe treatment for elderly patients with comorbidities, highlighting the need for further investigations.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Randomized controlled trial shows lidocaine's efficacy in inhibiting duodenal peristalsis in elderly patients, suggesting a safe alternative to existing treatments.

Cite This Study

Suzuki et al. (2025) studied this question.

synapsesocial.com/papers/692b9da01d383f2b2a37a3c4 https://doi.org/10.1002/deo2.70252

View Full Paper

Ask AI

Bookmark

Implication

Randomized controlled trial shows lidocaine's efficacy in inhibiting duodenal peristalsis in elderly patients, suggesting a safe alternative to existing treatments.

Inhibitory Effect of Lidocaine on Duodenal Peristalsis During Endoscopic Retrograde Cholangiopancreatography: A Multicenter, Randomized Controlled Trial (With Video)

Key Points

Discussion

Implication

Cite This Study

Inhibitory Effect of Lidocaine on Duodenal Peristalsis During Endoscopic Retrograde Cholangiopancreatography: A Multicenter, Randomized Controlled Trial (With Video)

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider